SCT520FF
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCT520FF, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD [Phase 1, Phase 2]